rank	phenotype	cui	assoc in neigh	assoc in intom	probability	Benjamini-Hochberg	genes	
10	Classical Hodgkin's Lymphoma	C1333064	5	126	2.43665088107e-11	8.984725965858042e-06	SOCS1,STAT5A,SOCS3,STAT5B,JAK2
11	Prolactinoma, familial	C0033375	5	95	2.71112021721e-11	9.883198562443846e-06	STAT5A,GH1,STAT5B,PRL,PRLR
12	Ovarian epithelial cancer	C0677886	11	2172	2.82529555307e-11	1.0781671159029651e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,STAT5B,JAK2,PRL,PTPN6,PRLR
14	Polycythemia vera	C0032463	6	192	3.34294814053e-11	1.2578616352201259e-05	SOCS1,STAT5A,SOCS3,STAT5B,JAK2,PTPN6
15	Prostate carcinoma	C0600139	12	2734	3.37370131831e-11	1.3477088948787063e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
16	Camptomelic dysplasia	C1861922	4	42	3.84862142155e-11	1.4375561545372868e-05	SOCS1,SOCS3,JAK2,PTPN6
18	Secondary hypertriglyceridemia	C0027627	12	3444	4.27016200177e-11	1.6172506738544477e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
19	Non-Hodgkin lymphoma	C0024305	8	556	4.93841634253e-11	1.707097933513028e-05	STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,PRL,PRLR
20	Myelofibrosis	C0026987	5	102	5.37604405437e-11	1.7969451931716083e-05	SOCS1,STAT5A,SOCS3,STAT5B,JAK2
21	Obesity	C0028754	11	2181	5.87685455855e-11	1.8867924528301888e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,GH2,STAT5B,JAK2,PRL,PTPN6
24	Neoplasm of the liver	C0023903	9	1290	6.60472787573e-11	2.1563342318059302e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,PRL,PRLR
25	Malignant tumor of prostate	C0376358	12	2940	6.73495703651e-11	2.2461814914645103e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
26	Myeloproliferative Disorders	C0027022	7	245	6.75729472377e-11	2.3360287511230908e-05	SOCS1,CSH1,STAT5A,SOCS3,STAT5B,JAK2,PTPN6
27	Somatotroph adenoma	C0346302	4	45	7.76485542531e-11	2.4258760107816713e-05	CSH1,GHR,GH1,PRL
28	Mammary Carcinoma, Human	C1257930	4	45	7.76485542531e-11	2.5157232704402517e-05	STAT5A,GH1,STAT5B,PRL
29	Carcinogenesis	C0596263	12	3723	8.04224464801e-11	2.605570530098832e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
30	Myeloproliferative disorder (2)	C1292778	6	165	8.28824786581e-11	2.6954177897574127e-05	SOCS1,STAT5A,SOCS3,STAT5B,JAK2,PTPN6
31	Essential thrombocythemia	C0040028	5	150	8.63733529144e-11	2.7852650494159928e-05	SOCS1,STAT5A,SOCS3,STAT5B,JAK2
32	Tumor Progression	C0178874	10	1969	8.85452822175e-11	2.8751123090745736e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6
33	Sezary Syndrome	C0036920	5	151	9.06704711312e-11	2.9649595687331537e-05	STAT5A,SOCS3,STAT5B,JAK2,PTPN6
34	Lymphoma, Large B-Cell, Diffuse	C0024299	9	1362	9.25366450133e-11	3.0548068283917345e-05	SOCS1,STAT5A,PTPN1,GH2,STAT5B,JAK2,PRL,PTPN6,PRLR
35	Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease	C0221013	4	58	1.01248565088e-10	3.144654088050314e-05	STAT5A,STAT5B,JAK2,PTPN6
36	Breast carcinoma	C0678222	12	4281	1.15160769809e-10	3.2345013477088955e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
37	Pituitary Neoplasms	C0032019	6	321	1.58639879011e-10	3.324348607367475e-05	SOCS1,CSH1,GHR,GH1,GH2,PRL
38	Hepatocellular carcinoma	C2239176	11	3108	1.73105751955e-10	3.414195867026056e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
39	Diabetic Nephropathies	C0011881	7	616	1.83563830802e-10	3.504043126684636e-05	STAT5A,GHR,GH1,PTPN1,STAT5B,JAK2,PTPN6
41	Abnormality of the pituitary gland	C0032002	7	645	2.02808436711e-10	3.6837376460017964e-05	CSH1,GHR,GH1,GH2,STAT5B,PRL,PRLR
42	Acromegaly	C0001206	4	70	2.12674322597e-10	3.7735849056603776e-05	CSH1,GHR,GH1,PRL
43	Breast-ovarian cancer, familial 1	C0006142	12	4543	2.342321892e-10	3.863432165318958e-05	SOCS1,CSH1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6,PRLR
45	Primary Myelofibrosis	C0001815	5	179	2.5207413934e-10	4.043126684636118e-05	SOCS1,STAT5A,SOCS3,STAT5B,JAK2
46	Animal Mammary Neoplasms	C0024667	10	2352	3.05030778414e-10	4.132973944294699e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PRLR
47	Lymphoma, Follicular	C0024301	6	389	3.17320947296e-10	4.222821203953279e-05	SOCS1,STAT5A,SOCS3,STAT5B,PRL,PTPN6
48	Diabetes mellitus type 1	C0011854	8	1104	3.4443270458e-10	4.3126684636118604e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2
49	Hodgkin Disease	C0019829	6	409	4.20887769081e-10	4.40251572327044e-05	SOCS1,STAT5A,GH1,PTPN1,STAT5B,JAK2
50	 Adenocarcinoma, ovarian, somatic, 167000 (3)	C0001418	9	1700	4.32158198116e-10	4.4923629829290206e-05	SOCS1,STAT5A,GHR,GH1,SOCS3,GH2,STAT5B,PRL,PRLR
51	Colorectal cancer 1	C0009402	10	2543	6.24622797929e-10	4.582210242587601e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6
52	Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia	C0271561	4	91	6.59454379992e-10	4.6720575022461816e-05	GHR,GH1,PTPN1,STAT5B
54	Colorectal cancer	C1527249	10	2681	1.09851683305e-09	4.8517520215633425e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6
55	Isolated somatotropin deficiency	C3714796	3	30	1.12758957727e-09	4.941599281221923e-05	GHR,GH1,STAT5B
56	Squamous cell carcinoma of the head and neck	C1168401	7	825	1.2799468152e-09	5.0314465408805034e-05	SOCS1,CSH1,STAT5A,SOCS3,STAT5B,JAK2,PRLR
57	Chronic myeloid leukemia	C0023473	7	822	1.28022881185e-09	5.121293800539083e-05	SOCS1,STAT5A,PTPN1,SOCS3,STAT5B,JAK2,PTPN6
58	Isolated growth hormone deficiency type 1B	C0013338	3	32	1.50233936402e-09	5.211141060197664e-05	GHR,GH1,PRL
59	Cutaneous T-cell lymphoma	C0079773	5	255	1.51152712569e-09	5.300988319856245e-05	STAT5A,SOCS3,STAT5B,JAK2,PTPN6
63	Chronic eosinophilic leukemia	C0346421	3	35	2.14849127378e-09	5.660377358490566e-05	STAT5A,STAT5B,JAK2
64	Malnutrition	C0162429	4	122	2.89258306196e-09	5.750224618149147e-05	STAT5A,GHR,GH1,STAT5B
65	Pituitary adenoma	C0032000	5	286	2.98621061212e-09	5.840071877807727e-05	SOCS1,CSH1,GHR,GH1,PRL
68	Lupus Erythematosus, Systemic	C0024141	8	1467	3.81325904186e-09	6.109613656783469e-05	SOCS1,STAT5A,GHR,SOCS3,JAK2,PRL,PTPN6,PRLR
69	Liver Diseases	C0023895	6	586	4.86553641821e-09	6.199460916442049e-05	SOCS1,GHR,GH1,PTPN1,SOCS3,JAK2
71	Mammary Tumorigenesis	C1512981	4	141	5.91023352481e-09	6.37915543575921e-05	STAT5A,GH1,JAK2,PRL
72	Panhypopituitarism X-linked	C0242343	3	45	5.9439063671e-09	6.469002695417791e-05	GHR,GH1,PRL
73	Prostatic Neoplasms	C0033578	8	1606	8.38625469068e-09	6.558849955076371e-05	STAT5A,GHR,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6
74	Metabolic Syndrome X	C0524620	6	638	8.76985484233e-09	6.64869721473495e-05	CSH1,GHR,GH1,PTPN1,SOCS3,GH2
75	Severe congenital neutropenia	C1853118	3	50	9.1408393077e-09	6.73854447439353e-05	STAT5A,STAT5B,PTPN6
76	Leukemia, T-cell acute lymphoblastoid (2)	C0023492	5	348	9.59421275759e-09	6.828391734052111e-05	SOCS1,STAT5A,STAT5B,JAK2,PTPN6
77	Insulinoma	C0021670	4	157	1.00789085966e-08	6.918238993710691e-05	STAT5A,GH1,STAT5B,PRL
78	B-cell lymphoma	C0079731	6	652	1.01604215041e-08	7.008086253369272e-05	SOCS1,STAT5A,PTPN1,STAT5B,JAK2,PTPN6
79	Leukemogenesis	C0598766	6	660	1.09996264319e-08	7.097933513027853e-05	STAT5A,PTPN1,SOCS3,STAT5B,JAK2,PTPN6
80	Russell-Silver syndrome	C0175693	3	56	1.45000874641e-08	7.187780772686433e-05	CSH1,GH1,GH2
81	Cachexia	C0006625	4	171	1.54666606189e-08	7.277628032345014e-05	CSH1,STAT5A,GH1,SOCS3
82	Mastocytosis	C0024899	3	57	1.56120200101e-08	7.367475292003593e-05	STAT5A,STAT5B,JAK2
83	Acute myeloid leukemia	C0023467	8	1733	1.63557395405e-08	7.457322551662174e-05	SOCS1,STAT5A,PTPN1,SOCS3,STAT5B,JAK2,PRL,PTPN6
86	Hormone receptor positive tumor	C1446409	3	61	2.05789485452e-08	7.726864330637916e-05	STAT5A,STAT5B,JAK2
90	Proportionate short stature	C0205351	3	65	2.66218294076e-08	8.086253369272237e-05	GHR,GH1,STAT5B
91	Leukemia, Lymphocytic, Chronic, B-Cell	C0023418	8	1913	3.87035852256e-08	8.176100628930818e-05	SOCS1,CSH1,STAT5A,SOCS3,STAT5B,JAK2,PRL,PTPN6
92	Mammary Neoplasms, Experimental	C0024668	4	207	4.02397829502e-08	8.265947888589398e-05	STAT5A,GH1,PRL,PRLR
95	BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4	C1140680	8	1967	4.93122555012e-08	8.53548966756514e-05	SOCS1,GH1,PTPN1,STAT5B,JAK2,PRL,PTPN6,PRLR
96	Myeloid neoplasm with beta-type platelet-derived growth factor receptor gene rearrangement	C2939461	3	76	5.02351321652e-08	8.625336927223721e-05	STAT5A,STAT5B,JAK2
97	Diabetes mellitus type 2	C0011860	8	1972	5.04536762369e-08	8.7151841868823e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,GH2,JAK2
98	Testicular seminoma	C0036631	4	222	5.70209230943e-08	8.80503144654088e-05	SOCS1,CSH1,GH1,GH2
100	Eczema	C0013595	5	474	6.00227618719e-08	8.984725965858041e-05	SOCS1,STAT5A,SOCS3,STAT5B,PTPN6
101	Growth Disorders	C0018273	3	81	6.50481147835e-08	9.074573225516622e-05	GHR,GH1,JAK2
102	Polycythemia	C0032461	3	81	6.50481147835e-08	9.164420485175202e-05	SOCS1,GH1,JAK2
103	Psoriasis	C0033860	6	878	7.80728814931e-08	9.254267744833783e-05	SOCS1,GH1,SOCS3,JAK2,PRL,PTPN6
104	Diabetes Mellitus, Type 1	C0011849	8	2081	8.05561373163e-08	9.344115004492363e-05	SOCS1,STAT5A,GHR,GH1,PTPN1,SOCS3,STAT5B,PTPN6
105	Autoimmune disease 1	C0004364	6	890	8.56329377408e-08	9.433962264150944e-05	SOCS1,STAT5A,STAT5B,JAK2,PRL,PTPN6
106	Liver Cirrhosis, Biliary	C0023890	6	919	1.06632218722e-07	9.523809523809524e-05	SOCS1,GHR,GH1,SOCS3,JAK2,PRLR
107	Germ cell neoplasia	C0205851	4	252	1.07159036311e-07	9.613656783468104e-05	SOCS1,CSH1,GH1,GH2
108	Endotoxemia	C0376618	3	96	1.29339010946e-07	9.703504043126685e-05	GHR,SOCS3,STAT5B
110	Hypoglycemia, neonatal, simulating foetopathia diabetica	C0020615	4	265	1.37683664025e-07	9.883198562443846e-05	GHR,GH1,SOCS3,PRL
111	Crohn Disease	C0010346	6	979	1.64088832855e-07	9.973045822102427e-05	SOCS1,STAT5A,GH1,SOCS3,STAT5B,JAK2
112	Dermatitis, Atopic	C0011615	5	567	1.72822699929e-07	0.00010062893081761007	SOCS1,STAT5A,SOCS3,STAT5B,PTPN6
116	Immunodeficiency due to defect in CD3-gamma	C0021051	5	571	1.80099001379e-07	0.00010422282120395327	STAT5A,PTPN1,STAT5B,JAK2,PRL
130	T-cell lymphoma	C0079772	4	302	2.63166096137e-07	0.00011680143755615454	SOCS3,STAT5B,JAK2,PTPN6
131	Lipomatosis, Multiple	C3489413	2	26	2.6415113108e-07	0.00011769991015274034	STAT5A,STAT5B
132	Peritonitis	C0031154	3	115	2.67696006917e-07	0.00011859838274932615	SOCS3,JAK2,PRL
133	Reperfusion Injury	C0035126	4	305	2.76377135955e-07	0.00011949685534591196	SOCS1,STAT5A,SOCS3,STAT5B
134	Juvenile myelomonocytic leukemia	C0349639	3	116	2.77172204299e-07	0.00012039532794249776	SOCS1,JAK2,PTPN6
135	Craniometaphyseal dysplasia, autosomal dominant	C1852502	2	27	2.97083763368e-07	0.00012129380053908357	GHR,JAK2
136	Alzheimer Disease	C0002395	7	1699	3.52290264849e-07	0.00012219227313566938	SOCS1,GHR,GH1,PTPN1,JAK2,PRL,PTPN6
137	Colon cancer	C0007102	7	1727	3.99574672572e-07	0.00012309074573225515	SOCS1,STAT5A,PTPN1,SOCS3,STAT5B,JAK2,PTPN6
138	T-Cell Prolymphocytic Leukemia	C0023494	2	30	4.11934712341e-07	0.00012398921832884098	STAT5A,STAT5B
139	Insulin Resistance	C0021655	4	332	4.20502113574e-07	0.00012488769092542677	SOCS1,GH1,PTPN1,JAK2
140	Obesity, severe, 601665 (3)	C0028756	3	131	4.5158934403e-07	0.00012578616352201257	GH1,PTPN1,PRL
141	Hypopituitarism	C0020635	3	131	4.5158934403e-07	0.00012668463611859837	GH1,STAT5B,PRL
142	Central hypothyroidism	C0271801	2	31	4.5591348341e-07	0.0001275831087151842	GH1,PRL
143	Fibrous Dysplasia	C0259779	2	31	4.5591348341e-07	0.00012848158131177	GHR,GH1
144	Multiple Sclerosis	C0026769	6	1140	4.61754118497e-07	0.00012938005390835582	SOCS1,SOCS3,JAK2,PRL,PTPN6,PRLR
145	Intraepithelial Neoplasia	C0878500	3	132	4.65625556445e-07	0.0001302785265049416	STAT5A,STAT5B,PRL
146	Philadelphia chromosome positive	C0856536	2	32	5.02982647532e-07	0.00013117699910152741	JAK2,PTPN6
147	Generalized osteoarthritis	C0409952	2	33	5.53068434272e-07	0.0001320754716981132	GHR,GH1
148	Lymphadenitis	C0024205	2	33	5.53068434272e-07	0.000132973944294699	SOCS1,SOCS3
149	Carney complex	C0406810	2	33	5.53068434272e-07	0.0001338724168912848	GH1,PRL
150	Hyperinsulinemia	C0020459	4	355	5.85364821171e-07	0.0001347708894878706	GH1,PTPN1,JAK2,PTPN6
151	X-linked severe combined immunodeficiency	C1279481	2	35	6.63103994269e-07	0.00013566936208445643	GHR,GH1
152	Carcinoma of colon	C0699790	7	1856	6.95061949219e-07	0.00013656783468104223	SOCS1,STAT5A,PTPN1,SOCS3,STAT5B,JAK2,PTPN6
171	Mediastinal (Thymic) Large B-Cell Lymphoma	C1292754	2	37	7.86740774639e-07	0.00015363881401617252	SOCS1,JAK2
172	Multiple Myeloma	C0026764	6	1236	7.97896482219e-07	0.00015453728661275832	SOCS1,STAT5A,SOCS3,STAT5B,JAK2,PTPN6
173	Symptomatic human immunodeficiency virus infection	C0019693	7	1900	8.31851685534e-07	0.00015543575920934412	SOCS1,STAT5A,GH1,SOCS3,STAT5B,PRL,PTPN6
174	B Acute Lymphoblastic Leukemia with t(9;22)(q34;q11.2); BCR-ABL1	C1292769	4	385	8.73184119232e-07	0.00015633423180592992	SOCS1,STAT5A,STAT5B,JAK2
175	Atherosclerosis	C0004153	6	1271	9.63383409602e-07	0.00015723270440251572	SOCS1,GH1,PTPN1,SOCS3,JAK2,PRL
176	46,XY gonadal dysgenesis, partial, with minifascicular neuropathy	C0041408	3	164	1.10929373875e-06	0.00015813117699910154	GHR,GH1,PTPN1
177	Primary Sj�gren's syndrome	C0205225	2	42	1.16060245281e-06	0.00015902964959568734	STAT5A,STAT5B
178	Vascular Diseases	C0042373	4	410	1.18997365184e-06	0.00015992812219227316	STAT5A,SOCS3,STAT5B,JAK2
179	Hematopoietic Neoplasms	C0376544	3	168	1.22128222302e-06	0.00016082659478885893	STAT5A,STAT5B,JAK2
190	Chondrodysplasia acromesomelic with genital anomalies	C0343284	2	45	1.43334409552e-06	0.0001707097933513028	STAT5A,STAT5B
191	Adolescent idiopathic scoliosis	C0410702	2	45	1.43334409552e-06	0.0001716082659478886	GHR,SOCS3
192	Pediatric Obesity	C2362324	2	46	1.53289013316e-06	0.00017250673854447442	GHR,GH1
193	Heart valve disease	C0018824	2	46	1.53289013316e-06	0.00017340521114106019	JAK2,PTPN6
194	Amyotrophy involving the shoulder musculature	C0026846	3	179	1.57255614375e-06	0.000174303683737646	STAT5A,GHR,GH1
195	Abnormality of the anterior pituitary	C4023206	3	181	1.64364424826e-06	0.0001752021563342318	GH1,STAT5B,PRLR
196	Chronic Kidney Insufficiency	C0403447	3	186	1.83208519444e-06	0.0001761006289308176	SOCS1,GH1,SOCS3
197	Rous Sarcoma	C0086942	2	49	1.85880169767e-06	0.00017699910152740343	GH1,PRL
198	Meningioma	C0025286	4	452	1.92087852724e-06	0.0001778975741239892	GHR,JAK2,PRL,PRLR
199	Acute Erythroblastic Leukemia	C0023440	3	195	2.21092853026e-06	0.00017879604672057503	STAT5A,STAT5B,JAK2
200	Adult T-Cell Lymphoma/Leukemia	C0023493	4	469	2.30180331617e-06	0.00017969451931716083	SOCS1,STAT5A,STAT5B,PTPN6
201	Urticaria Pigmentosa	C0042111	2	53	2.36071869497e-06	0.00018059299191374665	STAT5A,STAT5B
202	Primary hyperparathyroidism	C0221002	2	53	2.36071869497e-06	0.00018149146451033245	JAK2,PRLR
217	Malignant tumor of cervix	C0007847	5	889	2.39895297816e-06	0.00019496855345911953	SOCS1,STAT5A,SOCS3,STAT5B,JAK2
218	Leukemia, Large Granular Lymphocytic	C1522378	2	54	2.49878608338e-06	0.0001958670260557053	STAT5A,STAT5B
219	Acute myocardial ischemia	C0151744	4	484	2.68540784065e-06	0.0001967654986522911	STAT5A,GHR,SOCS3,JAK2
220	Leishmaniasis	C0023281	2	57	2.94514058718e-06	0.00019766397124887692	PTPN1,PTPN6
221	Burkitt lymphoma	C0006413	3	210	2.96778645648e-06	0.00019856244384546272	GH1,PRL,PTPN6
222	Maternal diabetes	C0085207	3	210	2.96778645648e-06	0.00019946091644204854	CSH1,GH1,GH2
223	Bronchiolitis, Viral	C0006274	3	211	3.02428058629e-06	0.0002003593890386343	STAT5A,SOCS3,JAK2
224	Osteosarcoma	C0585442	5	936	3.23383128431e-06	0.00020125786163522014	GHR,GH1,SOCS3,JAK2,PTPN6
225	Cowden syndrome 1	C0018553	2	59	3.27024755764e-06	0.00020215633423180594	STAT5A,STAT5B
226	Carcinoma, Lobular	C0206692	2	59	3.27024755764e-06	0.00020305480682839173	STAT5A,PRLR
227	Congenital hypothyroidism	C0010308	2	60	3.44133349461e-06	0.00020395327942497756	GHR,GH1
239	Blast Phase	C0005699	3	221	3.63409013926e-06	0.0002147349505840072	PTPN1,SOCS3,JAK2
240	Ductal Carcinoma	C1527349	3	223	3.7662510749e-06	0.000215633423180593	SOCS1,STAT5A,PRL
241	Liver failure acute infantile	C0085605	3	223	3.7662510749e-06	0.0002165318957771788	SOCS1,PTPN1,JAK2
242	Esophagitis	C0014868	2	62	3.80112520548e-06	0.00021743036837376458	GH1,GH2
243	Acute leukemia	C0085669	4	525	3.99552024644e-06	0.0002183288409703504	STAT5A,STAT5B,JAK2,PTPN6
244	Primary pulmonary hypertension	C0152171	3	227	4.04117232322e-06	0.0002192273135669362	STAT5A,STAT5B,JAK2
245	Adenomas, multiple colorectal, 608456 (3)	C0001430	5	975	4.09533601686e-06	0.00022012578616352203	GHR,GH1,GH2,PRL,PRLR
246	Lipoma	C0023798	2	65	4.3862108835e-06	0.00022102425876010783	STAT5A,STAT5B
247	Fibroadenoma of the breast	C0178421	2	66	4.59372500705e-06	0.00022192273135669362	PRL,PRLR
248	Noonan syndrome 1	C0028326	2	66	4.59372500705e-06	0.00022282120395327942	GH1,PTPN1
249	Mitral stenosis	C0026269	3	238	4.87416123729e-06	0.00022371967654986525	SOCS1,SOCS3,PTPN6
255	Glioblastoma	C0017636	6	1645	5.42817656202e-06	0.00022911051212938006	SOCS1,STAT5A,SOCS3,STAT5B,JAK2,PRL
256	Mammographic breast density	C1268717	2	70	5.48876638284e-06	0.0002300089847259659	GH1,PRL
257	Female infertility	C0021361	2	72	5.9765910978e-06	0.00023090745732255166	PRL,PRLR
258	Carcinoma of cervix	C0302592	5	1045	6.11038742704e-06	0.00023180592991913746	SOCS1,STAT5A,SOCS3,STAT5B,JAK2
259	Abnormality of the hypothalamus-pituitary axis	C4025819	3	252	6.11060897548e-06	0.00023270440251572328	GH1,STAT5B,PRLR
260	Neutropenia	C0027947	3	255	6.40320141487e-06	0.00023360287511230908	SOCS3,STAT5B,JAK2
261	Arteriosclerosis	C0003850	5	1059	6.59715841222e-06	0.0002345013477088949	SOCS1,GH1,PTPN1,SOCS3,JAK2
268	Eating disorder	C0013473	2	75	6.76079090656e-06	0.00024079065588499552	GH1,PRL
269	Spontaneous abortion	C0000786	3	260	6.91379413331e-06	0.00024168912848158131	JAK2,PRL,PRLR
270	Undifferentiated leukemia	C1378511	2	76	7.03652943135e-06	0.00024258760107816714	STAT5A,STAT5B
271	Abnormality of circulating hormone level	C4025652	3	262	7.12617037124e-06	0.0002434860736747529	GHR,GH1,STAT5B
272	Anaplastic large cell lymphoma, ALK negative	C0206180	3	263	7.23419453552e-06	0.00024438454627133876	SOCS1,SOCS3,PTPN6
273	Sepsis	C0243026	4	602	7.78012868041e-06	0.00024528301886792453	SOCS1,GHR,SOCS3,JAK2
274	Recurrent abortion	C0000809	2	79	7.90829887298e-06	0.0002461814914645103	PRL,PRLR
275	Metaplasia	C0025568	2	80	8.21398160256e-06	0.00024707996406109613	GH1,GH2
276	Acute Undifferentiated Leukemia	C0280141	2	81	8.52740832658e-06	0.00024797843665768195	STAT5A,STAT5B
277	Multiple Endocrine Neoplasia Type 1	C0025267	2	81	8.52740832658e-06	0.0002488769092542678	GH1,PRL
282	Hematological neoplasm	C0376545	4	615	8.63058261336e-06	0.00025336927223719674	SOCS1,STAT5A,STAT5B,JAK2
283	Failure to thrive	C0015544	4	622	9.11780062451e-06	0.00025426774483378257	CSH1,GHR,GH1,STAT5B
284	Choriocarcinoma	C0008497	3	279	9.13261517521e-06	0.0002551662174303684	CSH1,GH2,JAK2
285	Chronic active hepatitis	C0520463	2	86	1.02135392614e-05	0.0002560646900269542	CSH1,GH1
286	Liver regeneration disorder	C1318485	2	87	1.05752074308e-05	0.00025696316262354	PTPN1,SOCS3
287	Osteoporosis	C0029456	4	642	1.06299764548e-05	0.0002578616352201258	GHR,GH1,PRL,PRLR
296	Lung Neoplasms	C0024121	5	1155	1.08614897987e-05	0.000265947888589398	STAT5A,GHR,SOCS3,STAT5B,JAK2
297	Tuberculosis	C0041296	4	652	1.14564416264e-05	0.00026684636118598384	SOCS1,SOCS3,STAT5B,PRL
298	Respiratory Syncytial Virus Infections	C0035235	3	299	1.1995893864e-05	0.0002677448337825696	STAT5A,SOCS3,JAK2
299	Chronic Lymphocytic Leukemia	C0023434	5	1176	1.20428771391e-05	0.00026864330637915544	SOCS1,STAT5A,STAT5B,JAK2,PTPN6
300	Rheumatoid arthritis	C0003873	6	1856	1.208611265e-05	0.0002695417789757412	SOCS1,STAT5A,GH1,SOCS3,STAT5B,PRL
301	Leukopenia	C0023530	3	301	1.23147328537e-05	0.00027044025157232704	SOCS3,STAT5B,JAK2
302	Brain neoplasm	C0006118	4	667	1.27898378641e-05	0.00027133872416891286	STAT5A,SOCS3,STAT5B,JAK2
303	Glucose intolerance	C0271650	3	304	1.28047737832e-05	0.0002722371967654987	GHR,GH1,PTPN1
304	Parathyroid adenoma	C0262587	2	93	1.29241174589e-05	0.00027313566936208446	JAK2,PRLR
311	Nasopharyngeal carcinoma, susceptibility to, 3	C2931822	4	671	1.31652079841e-05	0.00027942497753818507	STAT5A,STAT5B,JAK2,PTPN6
312	Astrocytoma	C0004114	4	674	1.34522853221e-05	0.0002803234501347709	STAT5A,STAT5B,JAK2,PTPN6
313	Colitis, Ulcerative	C0009319	4	679	1.39418038639e-05	0.0002812219227313567	GH1,SOCS3,STAT5B,JAK2
314	Waldenstrom macroglobulinemia	C0024419	2	96	1.42176338004e-05	0.0002821203953279425	STAT5A,STAT5B
315	Pulmonary arterial hypertension	C3203102	3	314	1.45425818733e-05	0.0002830188679245283	STAT5A,STAT5B,JAK2
316	Leiomyoma	C0023267	3	316	1.49099932483e-05	0.00028391734052111414	GHR,GH1,PRL
317	Hyperplastic Polyp	C0333983	2	98	1.5125833162e-05	0.00028481581311769996	SOCS1,SOCS3
326	Recurrent tumor	C0521158	3	320	1.56654239272e-05	0.0002929020664869722	GH1,JAK2,PRL
327	Acute Coronary Syndrome	C0948089	3	320	1.56654239272e-05	0.000293800539083558	SOCS1,STAT5A,STAT5B
328	Leukemia, B-Cell	C2004493	2	100	1.60714671951e-05	0.0002946990116801437	JAK2,PTPN6
329	Respiratory distress	C0476273	2	102	1.70553978669e-05	0.00029559748427672954	STAT5B,PRL
330	Calcinosis	C0006663	2	103	1.75619148327e-05	0.00029649595687331536	JAK2,PTPN6
331	Uterine leiomyoma	C0042133	3	331	1.78885213348e-05	0.0002973944294699012	GHR,GH1,PRL
332	Metastatic melanoma	C0278883	3	333	1.83163882209e-05	0.00029829290206648696	SOCS1,STAT5A,JAK2
339	Hepatitis C	C0019196	4	721	1.86286930151e-05	0.00030458221024258757	SOCS1,STAT5A,SOCS3,PRL
340	Hypogonadism, diabetes mellitus, alopecia, mental retardation and electrocardiographic abnormalities	C0020619	3	337	1.91948313069e-05	0.0003054806828391734	GH1,PRL,PRLR
341	Non-small cell lung carcinoma	C0007131	6	1993	1.93263200056e-05	0.0003063791554357592	SOCS1,STAT5A,SOCS3,STAT5B,JAK2,PTPN6
342	Anterior hypopituitarism	C0302476	2	107	1.96871048537e-05	0.00030727762803234505	GH1,STAT5B
343	Chronic kidney disease	C1561643	3	342	2.03361065636e-05	0.0003081761006289308	SOCS1,GH1,SOCS3
344	Carcinoma breast stage IV	C0278488	3	342	2.03361065636e-05	0.00030907457322551664	STAT5B,PRL,PRLR
345	Prader-Willi syndrome	C0032897	2	109	2.08104622206e-05	0.00030997304582210247	GHR,GH1
346	Helicobacter Infections	C0079487	2	110	2.13876675812e-05	0.00031087151841868824	PTPN1,SOCS3
349	Dermatitis, Allergic Contact	C0162820	2	111	2.19753431731e-05	0.00031356693620844566	SOCS1,SOCS3
350	Portal hypertension, noncirrhotic	C0020541	2	112	2.257354821e-05	0.00031446540880503143	JAK2,PRL
356	{Gastric cancer risk after H. pylori infection}, 137215 (3)	C0024623	6	2073	2.50242982213e-05	0.0003198562443845463	SOCS1,GHR,PTPN1,SOCS3,JAK2,PTPN6
357	Breast adenocarcinoma	C0858252	2	116	2.50736037383e-05	0.00032075471698113204	PRL,PTPN6
358	Solid tumour	C0280100	4	772	2.58887310369e-05	0.00032165318957771787	SOCS1,STAT5A,SOCS3,JAK2
359	Stomach cancer	C0699791	6	2109	2.80122427743e-05	0.0003225516621743037	SOCS1,GHR,PTPN1,SOCS3,JAK2,PTPN6
360	Gallbladder disease 4	C0012634	4	785	2.80520762832e-05	0.00032345013477088946	STAT5A,GHR,GH1,JAK2
368	Hepatitis	C0019159	3	377	2.97805170748e-05	0.0003306379155435759	SOCS1,SOCS3,JAK2
369	Premature ovarian failure	C0025322	2	123	2.98754657976e-05	0.0003315363881401617	PRL,PRLR
370	Impotence	C0242350	2	126	3.21057918657e-05	0.00033243486073674755	GH1,PRL
376	Acute lymphoid leukemia	C0023449	4	824	3.54006794691e-05	0.00033782569631626234	STAT5A,STAT5B,JAK2,PTPN6
382	Schwannoma	C0027809	2	132	3.68897709819e-05	0.0003432165318957772	STAT5A,STAT5B
383	Ulcerative colitis	C0009324	4	837	3.81577151568e-05	0.000344115004492363	SOCS1,STAT5A,SOCS3,JAK2
384	Abdominal obesity	C0311277	2	134	3.85826523177e-05	0.00034501347708894883	GHR,GH1
385	Asthma	C0004096	5	1454	4.03007820176e-05	0.0003459119496855346	SOCS1,STAT5A,SOCS3,JAK2,PTPN6
389	Precursor Cell Lymphoblastic Leukemia-Lymphoma	C1961102	4	854	4.2012872391e-05	0.0003495058400718778	STAT5A,STAT5B,JAK2,PTPN6
394	Autism 15	C0004352	4	868	4.54103643972e-05	0.00035399820305480686	GHR,GH1,PRL,PRLR
395	Benign Prostatic Hyperplasia	C1704272	3	423	4.66679676034e-05	0.0003548966756513927	GH1,JAK2,PRL
396	Chronic liver disease	C0341439	2	144	4.78161550069e-05	0.0003557951482479784	SOCS1,JAK2
397	Abnormality of the endocrine system	C4025823	4	878	4.7965494714e-05	0.00035669362084456423	GHR,GH1,STAT5B,PRLR
401	Cancer of Head and Neck	C0278996	3	430	4.97472465881e-05	0.0003602875112309075	STAT5A,SOCS3,STAT5B
402	Glioblastoma multiforme	C1621958	3	434	5.15724616792e-05	0.0003611859838274933	SOCS1,SOCS3,JAK2
403	C-like syndrome	C0039082	3	438	5.34462486314e-05	0.00036208445642407907	CSH1,GHR,JAK2
404	Hypohidrosis	C0020620	2	150	5.39960161917e-05	0.0003629829290206649	GHR,JAK2
407	Amenorrhea	C0002453	2	151	5.5074364136e-05	0.00036567834681042226	PRL,PRLR
408	Secondary malignant neoplasm of pancreas	C3266877	5	1540	5.57380373581e-05	0.0003665768194070081	SOCS1,GHR,GH1,SOCS3,PRL
409	Tumor Angiogenesis	C1519670	3	443	5.58581917151e-05	0.0003674752920035939	GH1,JAK2,PRL
410	Neurofibromatosis, type 1, 162200 (3)	C0027831	2	152	5.61667971535e-05	0.0003683737646001797	GH1,JAK2
411	Familial cancer of breast	C0346153	2	155	5.95290784502e-05	0.0003692722371967655	JAK2,PRL
414	Melanoma	C0025202	6	2386	6.2586372845e-05	0.00037196765498652293	SOCS1,GHR,GH1,SOCS3,STAT5B,JAK2
415	Monosomy	C0026499	2	158	6.30208605976e-05	0.0003728661275831087	STAT5A,STAT5B
421	Abnormality of the menstrual cycle	C4025888	2	163	6.91344030382e-05	0.00037825696316262354	GHR,PRLR
422	Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay	C0013336	4	949	6.94920712574e-05	0.00037915543575920937	GHR,GH1,STAT5B,PRL
423	Pleural Tuberculosis	C0041326	1	25	7.09283977149e-05	0.0003800539083557952	SOCS3
424	Lobular carcinoma in situ of breast	C0279563	1	25	7.09283977149e-05	0.00038095238095238096	PRLR
425	Female hypogonadism	C0271578	1	25	7.09283977149e-05	0.00038185085354896673	PRLR
426	Neuroblastoma	C0700095	5	1612	7.20655640185e-05	0.00038274932614555256	STAT5A,SOCS3,STAT5B,JAK2,PRL
427	Abnormality of blood glucose concentration	C4023597	2	166	7.29825123563e-05	0.0003836477987421384	GHR,GH1
428	Thrombophilia due to activated protein C resistance	C1861171	1	26	7.68170686319e-05	0.00038454627133872415	JAK2
429	Acute-Phase Reaction	C0001349	1	26	7.68170686319e-05	0.00038544474393531	STAT5B
430	Granulocytic Sarcoma	C0152276	1	26	7.68170686319e-05	0.0003863432165318958	JAK2
431	Estrogen resistance	C3809250	1	26	7.68170686319e-05	0.0003872416891284816	PRL
432	Hypereosinophilic syndrome	C1540912	1	26	7.68170686319e-05	0.0003881401617250674	JAK2
433	Dermatosis NOS	C0037274	3	483	7.81298345548e-05	0.0003890386343216532	SOCS1,JAK2,PTPN6
434	Hypertension	C0020538	5	1647	8.1291710235e-05	0.00038993710691823905	GHR,GH1,PTPN1,JAK2,PRL
435	Gallbladder adenocarcinoma	C0279651	1	27	8.29386773801e-05	0.00039083557951482477	JAK2
436	Esophageal varix	C0014867	1	27	8.29386773801e-05	0.0003917340521114106	JAK2
437	Bulimia	C0006370	1	27	8.29386773801e-05	0.0003926325247079964	GHR
438	Cardiovascular morbidity	C1301700	1	27	8.29386773801e-05	0.0003935309973045822	GH1
439	Disorders of parathyroid gland	C0030517	1	27	8.29386773801e-05	0.000394429469901168	PRL
440	Lymphoma, Large-Cell, Follicular	C0079745	2	176	8.6817561466e-05	0.00039532794249775384	STAT5A,STAT5B
441	Idiopathic hypereosinophilic syndrome	C0206141	1	28	8.92929657865e-05	0.00039622641509433966	JAK2
442	Pseudohypoparathyroidism, Type Ia	C3494506	1	28	8.92929657865e-05	0.00039712488769092543	GH1
443	Smith-Magenis syndrome	C0795864	1	28	8.92929657865e-05	0.00039802336028751126	GH1
444	Familial X-linked hypophosphatemic vitamin D refractory rickets	C3536984	1	28	8.92929657865e-05	0.0003989218328840971	GH1
445	Septo-optic dysplasia sequence	C0338503	1	28	8.92929657865e-05	0.0003998203054806828	GH1
446	Thrombosis of retinal vein	C0035328	1	28	8.92929657865e-05	0.0004007187780772686	JAK2
447	Fulminant hepatitis	C0302809	1	28	8.92929657865e-05	0.00040161725067385445	SOCS1
448	High pitched voice	C0241703	1	28	8.92929657865e-05	0.0004025157232704403	GHR
449	Achondroplasia	C0001080	1	28	8.92929657865e-05	0.00040341419586702605	GH1
450	Adrenal Gland Hyperfunction	C0001622	1	28	8.92929657865e-05	0.00040431266846361187	GH1
451	Menstrual irregularities	C0156404	2	180	9.27989943512e-05	0.0004052111410601977	GHR,PRLR
452	Seborheic dermatitis	C0011603	2	181	9.43352934123e-05	0.00040610961365678347	STAT5A,STAT5B
453	Pituitary dependent hypercortisolism	C0221406	1	29	9.58797854748e-05	0.0004070080862533693	GHR
454	Melioidosis, susceptibility to	C0025229	1	29	9.58797854748e-05	0.0004079065588499551	PTPN6
455	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	C1292772	1	29	9.58797854748e-05	0.0004088050314465409	JAK2
456	Chromosomal translocation	C0040715	1	29	9.58797854748e-05	0.00040970350404312666	JAK2
457	Hypogonadotropic hypogonadism 7 with or without anosmia	C0022735	2	183	9.74577378345e-05	0.0004106019766397125	GH1,PRL
458	Status epilepticus	C0038220	2	185	0.000100646963948	0.0004115004492362983	SOCS1,SOCS3
459	Melanocytic nevus	C0027962	2	185	0.000100646963948	0.00041239892183288413	SOCS1,GH1
460	Tinnitus	C0040264	1	30	0.000102698906924	0.0004132973944294699	JAK2
461	Pseudohypoparathyroidism type 1A	C0033806	1	30	0.000102698906924	0.00041419586702605573	GH1
462	Spinal muscular atrophy with congenital bone fractures 2	C0026847	2	187	0.000103903810765	0.00041509433962264155	STAT5A,STAT5B
463	Adenocarcinoma of the large intestine	C1319315	2	189	0.000107228823313	0.0004159928122192273	STAT5A,STAT5B
464	Aortic Aneurysm, Abdominal	C0162871	2	190	0.00010891702778	0.0004168912848158131	STAT5A,STAT5B
465	Intermittent claudication	C0021775	1	31	0.000109750127468	0.0004177897574123989	JAK2
466	Creutzfeldt-Jakob Disease, Sporadic	C1852467	1	31	0.000109750127468	0.00041868823000898475	GH1
467	Chronic leukemia	C1279296	1	31	0.000109750127468	0.0004195867026055705	JAK2
468	Monocytosis	C0085702	1	31	0.000109750127468	0.00042048517520215634	JAK2
469	Gingival bleeding	C0017565	1	31	0.000109750127468	0.00042138364779874217	JAK2
470	Myeloid leukemia	C0023470	3	533	0.000114359836814	0.00042228212039532794	STAT5A,STAT5B,JAK2
471	Oligomenorrhea	C0028949	1	32	0.000117033329528	0.00042318059299191376	PRLR
472	Respiratory Hypersensitivity	C0035228	1	32	0.000117033329528	0.0004240790655884996	PTPN6
473	Puerperal Disorders	C0034040	1	32	0.000117033329528	0.0004249775381850854	PRL
474	Immune dysfunction with T-cell inactivation due to calcium entry defect 1	C0021053	2	197	0.000121223484536	0.00042587601078167113	SOCS3,STAT5B
475	Severe combined immunodeficiency due to ADA deficiency	C0085110	3	545	0.000124616809016	0.00042677448337825695	STAT5A,GHR,JAK2
476	Ovarian Failure, Premature	C0085215	2	199	0.000124899053488	0.0004276729559748428	PRL,PRLR
477	Xenograft Model	C1520166	3	551	0.000129989419339	0.00042857142857142855	GH1,SOCS3,JAK2
478	Exertional dyspnea	C0231807	1	34	0.000132294468251	0.0004294699011680144	JAK2
479	Acinar Cell Carcinoma	C0206685	1	34	0.000132294468251	0.0004303683737646002	PRLR
480	Cushing's syndrome	C0010481	1	34	0.000132294468251	0.000431266846361186	GH1
481	Erythrocytosis	C1527405	1	34	0.000132294468251	0.0004321653189577718	JAK2
482	Hypervolemia	C0546817	1	34	0.000132294468251	0.0004330637915543576	GH1
483	Transient ischemic attack	C0007787	2	205	0.000136360815044	0.00043396226415094345	JAK2,PRL
484	Enterovirus Infections	C0014378	1	35	0.000140272201083	0.00043486073674752916	SOCS1
485	Enteritis	C0014335	1	35	0.000140272201083	0.000435759209344115	STAT5B
486	Acquired scoliosis	C0700208	1	35	0.000140272201083	0.0004366576819407008	GH1
487	Resistance to activated protein C	C0600433	1	35	0.000140272201083	0.00043755615453728664	JAK2
488	Myelosuppression	C0854467	1	35	0.000140272201083	0.0004384546271338724	JAK2
489	Ileitis	C0020877	1	35	0.000140272201083	0.00043935309973045823	GH1
490	Dyspnea	C0013404	2	209	0.000144370766746	0.00044025157232704406	STAT5B,JAK2
491	Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma	C0079744	3	568	0.000146128977682	0.00044115004492362983	SOCS1,JAK2,PTPN6
492	Complete trisomy 18 syndrome	C0152096	1	36	0.000148480934912	0.00044204851752021565	GH1
493	Prolonged bleeding time	C0439590	1	36	0.000148480934912	0.0004429469901168015	JAK2
494	Abnormal delivery	C0549629	1	37	0.000156920639776	0.00044384546271338725	JAK2
495	Peripheral artery occlusive disease	C1306889	1	37	0.000156920639776	0.000444743935309973	JAK2
496	Genomic Instability	C0919532	1	37	0.000156920639776	0.00044564240790655884	JAK2
497	Serositis	C0036749	1	37	0.000156920639776	0.00044654088050314467	JAK2
498	Mesenchymal Cell Neoplasm	C1334699	1	37	0.000156920639776	0.0004474393530997305	JAK2
499	Squamous cell carcinoma	C0007137	5	1855	0.000157794586394	0.00044833782569631627	SOCS1,STAT5A,SOCS3,JAK2,PTPN6
500	Tuberculosis, Pulmonary	C0041327	2	218	0.000163501335875	0.0004492362982929021	SOCS1,SOCS3
501	End Stage Liver Disease	C0745744	1	38	0.000165590969313	0.0004501347708894879	GHR
502	Ovarian hyperstimulation syndrome	C0085083	1	38	0.000165590969313	0.0004510332434860737	SOCS1
503	Personality disorder	C0031212	1	38	0.000165590969313	0.00045193171608265946	PRL
504	Chromosome 5, trisomy 5q	C1802398	1	38	0.000165590969313	0.0004528301886792453	JAK2
505	Pregnancy in Diabetics	C0032969	1	38	0.000165590969313	0.0004537286612758311	GH2
506	Gastro-esophageal reflux disease with esophagitis	C0677659	1	39	0.000174491894656	0.0004546271338724169	GHR
507	Breast hypoplasia	C0266013	1	39	0.000174491894656	0.0004555256064690027	GH1
508	Pancreatitis, Acute Necrotizing	C0267941	1	39	0.000174491894656	0.00045642407906558853	GH1
509	Malabsorption	C0024523	2	224	0.000177129772812	0.0004573225516621743	GH1,JAK2
510	Rhinovirus infection	C0276447	1	40	0.00018362301382	0.0004582210242587601	SOCS1
511	Keratoconjunctivitis	C0022573	1	40	0.00018362301382	0.00045911949685534595	GH1
512	Amaurosis fugax	C0149793	1	40	0.00018362301382	0.0004600179694519318	JAK2
513	Malignant hyperthermia susceptibility type 5	C0015967	2	228	0.000186614178211	0.0004609164420485175	JAK2,PRL
514	Arterial Occlusive Diseases	C0003838	1	41	0.000192984354031	0.0004618149146451033	JAK2
515	Neoplasm of the tongue	C0040411	1	41	0.000192984354031	0.00046271338724168914	PRL
516	Delayed skeletal maturation	C0541764	2	234	0.000201451150472	0.0004636118598382749	GHR,GH1
517	Active tuberculosis	C0151332	1	42	0.000202575485182	0.00046451033243486074	SOCS1
518	Schizophrenia	C0036341	5	1947	0.000206292110895	0.00046540880503144656	GHR,GH1,PTPN1,PRL,PTPN6
519	Hyperlipoproteinemia Type IIa	C0745103	1	43	0.000212396404187	0.0004663072776280324	GHR
520	Ectopic Pregnancy	C0032987	1	43	0.000212396404187	0.00046720575022461816	PRL
521	Hyperlipoproteinemia	C0020476	1	43	0.000212396404187	0.000468104222821204	GHR
522	Anemia	C0002871	3	627	0.000213574984443	0.0004690026954177898	JAK2,PRL,PTPN6
523	Pleural Mesothelioma	C0812413	2	240	0.000217035362706	0.0004699011680143755	SOCS1,SOCS3
524	Deep thrombophlebitis	C0151950	1	44	0.000222446771772	0.00047079964061096135	JAK2
525	Abnormality of the hepatic vasculature	C4024994	1	44	0.000222446771772	0.0004716981132075472	JAK2
526	Antisocial/borderline personality disorder	C0233523	1	44	0.000222446771772	0.000472596585804133	PRL
527	Congenital scoliosis	C0559260	1	44	0.000222446771772	0.00047349505840071877	GH1
528	Substance abuse problem	C0740858	1	44	0.000222446771772	0.0004743935309973046	PRL
529	Stroke	C0038454	4	1229	0.000235413372678	0.0004752920035938904	GHR,GH1,JAK2,PRL
530	Glioma	C0017638	5	1997	0.000237270105765	0.0004761904761904762	PTPN1,SOCS3,STAT5B,JAK2,PTPN6
531	Inflammation	C0021368	3	647	0.000240852358446	0.000477088948787062	SOCS1,GH1,SOCS3
532	Underdeveloped supraorbital ridges	C1861869	1	46	0.000243235293496	0.00047798742138364784	GHR
533	Photoparoxysmal response 1 (2)	C1868677	1	46	0.000243235293496	0.0004788858939802336	CSH1
534	Osteogenesis imperfecta	C0029434	1	46	0.000243235293496	0.0004797843665768194	GH1
535	Malignant tumor of esophagus	C0546837	3	650	0.000245151453565	0.0004806828391734052	GH1,GH2,JAK2
536	Isochromosomes	C0242621	1	47	0.000253973017877	0.00048158131176999103	JAK2
537	Varicella zoster	C0740380	1	47	0.000253973017877	0.00048247978436657686	SOCS3
538	Toxoplasmosis	C0040558	1	47	0.000253973017877	0.00048337825696316263	SOCS3
539	Renovascular hypertension	C0020545	1	48	0.000264939384156	0.00048427672955974845	PRL
540	Hypokalemia	C0020621	1	48	0.000264939384156	0.0004851752021563343	GH1
541	Cytogenetically normal acute myeloid leukemia	C3839868	1	48	0.000264939384156	0.00048607367475292005	JAK2
542	Hemophilia, NOS	C0684275	1	49	0.000276134306756	0.0004869721473495058	GH1
543	Sideroblastic anemia 3, pyridoxine-refractory	C0002896	1	49	0.000276134306756	0.00048787061994609164	JAK2
544	Osteopetrosis autosomal recessive 4	C0029454	1	49	0.000276134306756	0.0004887690925426775	GHR
545	Exostoses	C0015302	1	49	0.000276134306756	0.0004896675651392632	GH1
546	Osteitis Deformans	C0029401	1	49	0.000276134306756	0.0004905660377358491	PRL
547	Iron deficiency anemia	C0162316	1	50	0.000287557556067	0.0004914645103324349	JAK2
548	Malignant neoplasm of tongue	C0153349	1	50	0.000287557556067	0.0004923629829290206	PRL
549	Other rheumatic heart disease	C0035439	1	50	0.000287557556067	0.0004932614555256064	STAT5B
550	Abnormality of skeletal maturation	C4025818	2	268	0.000300122666897	0.0004941599281221923	GHR,GH1
551	Endometrial Neoplasms	C0014170	2	268	0.000300122666897	0.0004950584007187781	GH1,SOCS3
552	Esophageal Neoplasms	C0014859	3	686	0.000301182959599	0.0004959568733153639	GH1,GH2,JAK2
553	Ankylosing spondylitis	C0038013	2	269	0.000303418300975	0.0004968553459119497	SOCS1,JAK2
554	Diabetic Retinopathy	C0011884	2	270	0.000306737374385	0.0004977538185085356	GH1,PTPN1
555	Peptic Esophagitis	C0014869	1	52	0.000311088119223	0.0004986522911051213	GHR
556	Lehman syndrome	C1851710	1	52	0.000311088119223	0.0004995507637017071	SOCS3
557	Hepatitis B, Chronic	C0524909	2	272	0.000313445809276	0.0005004492362982928	SOCS1,JAK2
558	Bradycardia	C0428977	1	53	0.000323195118468	0.0005013477088948786	PRL
559	Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	C0549463	1	53	0.000323195118468	0.0005022461814914645	PTPN6
560	Oncocytic Neoplasm	C1378050	1	53	0.000323195118468	0.0005031446540880503	PRL
561	Tongue Carcinoma	C0558353	1	54	0.000335529529529	0.0005040431266846361	PRL
562	Endometrial Hyperplasia	C0014173	1	54	0.000335529529529	0.0005049415992812219	PRL
563	Refractory anemia	C0002893	1	55	0.000348091379809	0.0005058400718778078	JAK2
564	Carcinoma of Male Breast	C0238033	1	55	0.000348091379809	0.0005067385444743935	PRL
565	Refractory anaemia with excess blasts	C0002894	1	55	0.000348091379809	0.0005076370170709793	SOCS1
566	polyps	C0032584	2	284	0.000355698933377	0.0005085354896675651	SOCS1,SOCS3
567	Sicca Syndrome	C0086981	1	56	0.000360880242226	0.000509433962264151	PRL
568	Chronic neutrophilia	C3665444	1	57	0.000373896090131	0.0005103324348607368	JAK2
569	Joint swelling	C0152031	1	57	0.000373896090131	0.0005112309074573226	SOCS3
570	Dysmorphic features	C0432072	1	57	0.000373896090131	0.0005121293800539084	GH1
571	Medullary carcinoma	C0206693	1	57	0.000373896090131	0.0005130278526504941	PTPN6
572	Female pseudohermaphroditism	C0238394	1	57	0.000373896090131	0.00051392632524708	JAK2
573	Hutchinson-Gilford syndrome	C0033300	1	57	0.000373896090131	0.0005148247978436658	GH1
574	Endometriosis	C0014175	3	727	0.000375668776277	0.0005157232704402516	GH1,PRL,PRLR
575	Abnormal pulmonary vein morphology	C0241665	1	58	0.000387138604281	0.0005166217430368374	JAK2
576	Neoplasms, Experimental	C0027659	1	58	0.000387138604281	0.0005175202156334233	PRL
577	Blue sclerae	C0542514	1	58	0.000387138604281	0.000518418688230009	GHR
578	Abnormality of the basal ganglia	C0004782	1	58	0.000387138604281	0.0005193171608265947	PRL
579	Cockayne syndrome	C0009207	1	58	0.000387138604281	0.0005202156334231805	CSH1
580	Malignant tumor of urinary bladder	C0005684	4	1371	0.000391754340051	0.0005211141060197664	SOCS1,GHR,GH1,SOCS3
581	Chromosome 8, trisomy	C0008671	1	59	0.000400607707398	0.0005220125786163522	JAK2
582	Abnormality of cholesterol metabolism	C4025656	1	59	0.000400607707398	0.000522911051212938	GHR
583	Helicobacter pylori infection	C0850666	2	297	0.00040545174501	0.0005238095238095238	JAK2,PTPN6
584	Supraventricular tachycardia	C0039240	1	60	0.000414303079626	0.0005247079964061097	JAK2
585	X-linked agammaglobulinemia	C0221026	1	60	0.000414303079626	0.0005256064690026954	GH1
586	Gastrointestinal obstruction	C0236124	1	60	0.000414303079626	0.0005265049415992812	JAK2
587	Pancreatic Neoplasms	C0030297	3	750	0.000422834473104	0.000527403414195867	SOCS1,GH1,JAK2
588	Leukocytosis	C0023518	1	61	0.000428224608974	0.0005283018867924528	JAK2
589	Colonic Polyps	C0009376	1	61	0.000428224608974	0.0005292003593890387	GH1
590	Cooley's anemia	C0002875	1	61	0.000428224608974	0.0005300988319856245	GH1
591	Pancreatic intraepithelial neoplasia	C1301034	1	61	0.000428224608974	0.0005309973045822103	SOCS1
592	Kidney Diseases	C0022658	3	755	0.000433626658162	0.000531895777178796	GHR,GH1,SOCS3
593	Lung cancer	C0684249	5	2234	0.000438663672392	0.0005327942497753819	SOCS1,CSH1,SOCS3,STAT5B,JAK2
594	Hydatidiform mole, recurrent, 1, 231090 (3)	C3463897	1	62	0.00044237204078	0.0005336927223719677	GH1
595	Osteoarthritis of hip	C0029410	1	62	0.00044237204078	0.0005345911949685535	SOCS3
596	Epistaxis	C0014591	1	62	0.00044237204078	0.0005354896675651392	JAK2
597	Other specified disorders of breast	C0006145	1	62	0.00044237204078	0.0005363881401617251	PRL
598	Syncope	C0039070	1	62	0.00044237204078	0.0005372866127583109	JAK2
599	secondary acute myeloid leukemia	C0280449	1	63	0.000456745258883	0.0005381850853548967	JAK2
600	Persistent infection	C1264606	1	63	0.000456745258883	0.0005390835579514824	SOCS3
601	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 11	C0026850	2	311	0.00046383326776	0.0005399820305480682	STAT5A,GH1
602	Hyperpituitarism	C0020506	1	64	0.000471343928012	0.0005408805031446541	PRLR
603	Ascites	C0003962	1	65	0.000486167983033	0.0005417789757412399	JAK2
604	Abnormality of the gallbladder	C0266249	1	65	0.000486167983033	0.0005426774483378257	JAK2
605	Non-alcoholic Fatty Liver Disease	C0400966	2	317	0.000490424339587	0.0005435759209344115	PTPN1,JAK2
606	Abnormal bleeding	C1458140	2	319	0.000499501491322	0.0005444743935309974	JAK2,PRLR
607	Aqueous Humor Disorders	C0595936	1	66	0.000501217174442	0.0005453728661275831	PRL
608	Hypoxia-Ischemia, Brain	C0752308	1	66	0.000501217174442	0.0005462713387241689	GHR
609	Retinopathy of Prematurity	C0035344	1	68	0.000531990255163	0.0005471698113207547	PRL
610	Neoplasms, Intracranial	C1527390	1	68	0.000531990255163	0.0005480682839173406	PRL
611	Microalbuminuria	C0730345	1	68	0.000531990255163	0.0005489667565139264	GH1
612	Histiocytosis, Langerhans-Cell	C0019621	1	68	0.000531990255163	0.0005498652291105122	PTPN6
613	Disorder of endocrine system	C0014130	1	68	0.000531990255163	0.000550763701707098	GH1
614	 Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	C0206081	1	68	0.000531990255163	0.0005516621743036838	GH1
615	Pulmonic stenosis	C0034089	1	68	0.000531990255163	0.0005525606469002695	PTPN1
616	Pneumocystis jiroveci pneumonia	C1535939	1	69	0.000547713662506	0.0005534591194968553	SOCS1
617	Abnormality of the sclera	C4025840	1	69	0.000547713662506	0.0005543575920934411	GHR
618	Sleep apnea	C0037315	1	69	0.000547713662506	0.000555256064690027	GH1
619	Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	C0740394	1	69	0.000547713662506	0.0005561545372866128	JAK2
